Mancia et al. (2020) conducted a case-control study in the Lombardy region of Italy to examine the association between the use of angiotensin-converting-enzyme (ACE) inhibitors and the odds of coronavirus disease 2019 (COVID-19). There were 1,502 COVID-19 cases among the 8,071 patients who used ACE inhibitors. There were 4,770 COVID-19 cases among the 28,960 patients who did not use ACE inhibitors. Using a 0.05 significance level, you need to test the claim that the proportion of COVID-19 patients among those who used ACE inhibitors (group 1) is higher than the proportion of COVID-19 patients among those who did not use ACE inhibitors (group 2).
What proportion of ACE inhibitor users were not COVID-19 cases? (0.5 points)
Select one:
a. 0.14
b. 0.16
c. 0.19
d. 0.81
e. 0.84
sectetu
sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitae odio. Donec aliquet. Lorem ipsum dolor sit
secUnlock access to this and over
10,000 step-by-step explanations
Have an account? Log In
sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitae odio. Donec aliquet. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitae odio. Donec aliquet. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus eff
sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellente
sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitsectetu
sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, di
sectetur adsectetur adipiscing elit. Nam lacinia pulvinar tortorsectetur adipiscing elit. Nam lacinia pulvinar tortosectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisisectetur adipiscing elsectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilissectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesquesectetur adipiscing elit. Nam lasssecssssssecsssecssssecssssssecsssecssssecssssecsssecssssssssssssecsssecsssssssecssssssssssssecsssecsssssssecsecssssssecssssssecssssssectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Psectetur adipiscsectetur adipiscing elit. Nam laciniassssssecsssssecsssssssssectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Namsesectetsectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nsectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam rsectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dap
sectetur adipiscing elit. Nam lacinia pulvinar tortor nec facilisis. Pellentesque dapibus efficitur laoreet. Nam risus ante, dapibus a molestie consequat, ultrices ac magna. Fusce dui lectus, congue vel laoreet ac, dictum vitae odio. Donec aliquet. Lorem ipsum dolor sit